FdaApplication

BLA 761450

Back to search

Identifiers

Properties

PropertyValue
applicant_nameShanghai Henlius Biotech, Inc.
application_typeBLA
approval_date2025-11-13

Products (1)

ProductActive ingredientStrengthDosage form
POHERDYPERTUZUMAB-DPZB420MG/14ML (30MG/ML)Injection

1 product